Research on Complex Generics
HHS-FDA Posted RFA-FD-27-001
Close Date:
December 14, 2026
30 days remaining
Description
The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.
Eligibility
Only the following applicant is eligible to apply for this single source funding: The University of Maryland
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- $2,500,000.00
- Total Estimated Funding
- Not specified
- Expected Awards
- 1
Key Dates
- Posted
- November 13, 2026
- Closes
- December 14, 2026 30d
- Archive Date
- January 13, 2027
Agency Information
- Agency Name
- Food and Drug Administration
- Agency Code
- HHS-FDA
- Funding Instrument
- Other